Evidence map›Paper›PMID 33693634›Full record

ArticleEuropean journal of preventive cardiology2022

Abdominal and gluteo-femoral markers of adiposity and risk of vascular-metabolic mortality in a prospective study of 150 000 Mexican adults.

Louisa Gnatiuc, Roberto Tapia-Conyer, Rachel Wade, Raúl Ramirez-Reyes, Diego Aguilar-Ramirez, William Herrington, Michael Hill, Sarah Lewington, Jason Torres, Eirini Trichia and 6 more

Open access · hybridAbstract read
In one paragraph

Article in European journal of preventive cardiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 3 countries.

Louisa GnatiucClinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health (NDPH), University of Oxford, Oxford, UK.ORCID 0000-0002-0641-2220
Roberto Tapia-ConyerSchool of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.ORCID 0000-0003-3814-2904
Rachel WadeClinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health (NDPH), University of Oxford, Oxford, UK.ORCID 0000-0001-9826-6322
Raúl Ramirez-ReyesSchool of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.ORCID 0000-0001-9763-324X
Diego Aguilar-RamirezClinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health (NDPH), University of Oxford, Oxford, UK.ORCID 0000-0003-2298-3768
William HerringtonClinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health (NDPH), University of Oxford, Oxford, UK.ORCID 0000-0003-1172-8243
Michael HillClinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health (NDPH), University of Oxford, Oxford, UK.ORCID 0000-0002-3861-6105
Sarah LewingtonClinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health (NDPH), University of Oxford, Oxford, UK.ORCID 0000-0002-4496-4771
Jason TorresClinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health (NDPH), University of Oxford, Oxford, UK.ORCID 0000-0002-7537-7035
Eirini TrichiaClinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health (NDPH), University of Oxford, Oxford, UK.ORCID 0000-0002-7655-5905
Rory CollinsClinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health (NDPH), University of Oxford, Oxford, UK.ORCID 0000-0001-8288-8602
Richard PetoClinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health (NDPH), University of Oxford, Oxford, UK.ORCID 0000-0001-8219-5339
Robert ClarkeClinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health (NDPH), University of Oxford, Oxford, UK.ORCID 0000-0002-9802-8241
Pablo Kuri-MoralesSchool of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.ORCID 0000-0002-0704-9507
Jonathan R EmbersonClinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health (NDPH), University of Oxford, Oxford, UK.ORCID 0000-0001-7792-9422
Jesus Alegre-DíazSchool of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.ORCID 0000-0001-9390-3871
University of Oxford · GBUniversidad Nacional Autónoma de México · MXUniversity Kebangsaan Malaysia Medical Centre · MY

Funding

Breast Cancer NowBritish Heart Foundation RE/13/1/30181Medical Research Council MC_UU_00017/2Medical Research Council MR/R007764/1Wellcome Trust
6 · The paper itself

Abstract

aimsResults of previous studies of abdominal adiposity and risk of vascular-metabolic mortality in Hispanic populations have been conflicting. We report results from a large prospective study of Mexican adults with high levels of abdominal adiposity. METHODS AND

resultsA total of 159 755 adults aged ≥35 years from Mexico City were enrolled in a prospective study and followed for 16 years. Cox regression, adjusted for confounders, yielded mortality rate ratios (RRs) associated with three markers of abdominal adiposity (waist circumference, waist-hip ratio, and waist-height ratio) and one marker of gluteo-femoral adiposity (hip circumference) for cause-specific mortality before age 75 years. To reduce reverse causality, deaths in the first 5 years of follow-up and participants with diabetes or other prior chronic disease were excluded. Among 113 163 participants without prior disease and aged 35-74 years at recruitment, all adiposity markers were positively associated with vascular-metabolic mortality. Comparing the top versus bottom tenth of the sex-specific distributions, the vascular-metabolic mortality RRs at ages 40-74 years were 2.32 [95% confidence interval (CI) 1.84-2.94] for waist circumference, 2.22 (1.71-2.88) for the waist-hip ratio, 2.63 (2.06-3.36) for the waist-height ratio, and 1.58 (1.29-1.93) for hip circumference. The RRs corresponding to each standard deviation (SD) higher usual levels of these adiposity markers were 1.34 (95% CI 1.27-1.41), 1.31 (1.23-1.39), 1.38 (1.31-1.45), and 1.18 (1.13-1.24), respectively. For the markers of abdominal adiposity, the RRs did not change much after further adjustment for other adiposity markers, but for hip circumference the association was reversed; given body mass index and waist circumference, the RR for vascular-metabolic mortality for each one SD higher usual hip circumference was 0.80 (0.75-0.86).

conclusionsIn this study of Mexican adults, abdominal adiposity (and in particular the waist-height ratio) was strongly and positively associated with vascular-metabolic mortality. For a given amount of general and abdominal adiposity, however, higher hip circumference was associated with lower vascular-metabolic mortality.

Indexed as

AdiposityObesity, AbdominalAdultBiomarkersBody Mass IndexFemaleHumansMaleMexicoObesityProspective StudiesRisk FactorsWaist CircumferenceWaist-Hip RatioBiomarkersAbdominal adiposityCause-specific mortalityGluteo-femoral adiposityMexicoProspective cohort study

Identifiers

PMID33693634
PMCPMC9071366
OpenAlexW3131781958

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.